Gibeom Nam

发表

Discovery of a Simplified Deguelin Analog as an HSP90 C-terminal Inhibitor for HER2-positive Breast Cancer.

Hyun-Ju Park, Jihyae Ann, Jeewoo Lee, 2021, Bioorganic & medicinal chemistry letters.

A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer

Ji Young Kim, Hyun-Ju Park, J. Seo, 2020, Molecular Cancer.

Antithrombotic effect of SP‐8008, a benzoic acid derivative, through the selective inhibition of shear stress‐induced platelet aggregation

J. Chung, Hyun-Ju Park, Kiho Lee, 2020, British journal of pharmacology.

Ethyl Gallate Dual-Targeting PTPN6 and PPARγ Shows Anti-Diabetic and Anti-Obese Effects

Xiaodi Zhao, Sang J. Chung, S. Yoon, 2022, International journal of molecular sciences.

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response

J. Seo, Jihyae Ann, Jeewoo Lee, 2022, Oncogene.

Structure–Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition

Xiaodi Zhao, HyunA. Park, Sang J. Chung, 2022, International journal of molecular sciences.

Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).

Ji Young Kim, Hyun-Ju Park, Raghaba Sahu, 2020, Bioorganic & medicinal chemistry letters.

Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.

Hyun-Ju Park, Seung Yeop Baek, Y. Jung, 2019, Bioorganic & medicinal chemistry.

A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects

Hyun-Ju Park, Ho Jin Lee, Jihyae Ann, 2022, Theranostics.

Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer

Min Gyu Lee, Hyun-Ju Park, Jeung-Whan Han, 2019, BMC Cancer.

Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.

Hyun-Ju Park, Sungjun Kong, Y. Jung, 2023, Bioorganic & medicinal chemistry.

Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer

Min Gyu Lee, Hyun-Ju Park, Jeung-Whan Han, 2019, BMC Cancer.

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron

Sang J. Chung, Dohee Ahn, Gibeom Nam, 2023, Nutrients.

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer

Jihyae Ann, Jeewoo Lee, Soeun Park, 2024, Theranostics.

Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity.

Gibeom Nam, D. Bae, Changsik Lee, 2024, Bioorganic & medicinal chemistry.